search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


The Home Sweet Home study.


- candidate number14690
- NTR NumberNTR3941
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR8-apr-2013
- Secondary IDsNL42721.060.12 METC Catharina Ziekenhuis
- Public TitleThe Home Sweet Home study.
- Scientific TitleThe Home Sweet Home study: An observational, longitudinal study on the home environment of people with chronic obstructive pulmonary disease (COPD).
- ACRONYM
- hypothesis1. To investigate the differences between patients’ and resident loved ones' perceptions of patients’ health status and problematic ADLs;
2. To study prospectively the effects of an acute COPD exacerbation on resident loved ones' perceptions of patients’ health status and problematic ADLs.
- Healt Condition(s) or Problem(s) studiedChronic Obstructive Pulmonary Disease (COPD)
- Inclusion criteria1. COPD as main diagnosis (GOLD stage II, III or IV according to GOLD guidelines);
2. No exacerbation or hospitalization <4 weeks before enrolment;
3. Providing written informed consent;
4. One resident loved one also provided a written informed consent to participate.
- Exclusion criteria1. Unable to complete the study questionnaires because of cognitive impairment as determined by the ‘Short Blessed Test’, for both the patient as well as the loved one;
2. Unable to speak or understand Dutch, for both the patient as well as the loved one.
- mec approval receivedyes
- multicenter trialyes
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 1-mei-2013
- planned closingdate30-nov-2015
- Target number of participants384
- InterventionsN/A
- Primary outcomeThe resident loved one, their perception of the person with COPD, and the person with COPD will be compared by using the:
1. Problematic ADLs using the Canadian Occupational Performance Measure (COPM);
2. COPD Assessment Test (CAT);
3. mMRC dyspnea scale;
4. Short-Form 12;
5. Instrumental Activities of Daily Living Scale (IADLS);
6. EQ-5D;
7. Fatigue using the Subjective Fatigue subscale of the Checklist Individual Strength;
8. Self-efficacy for home walking.
- Secondary outcomeThe secondary study parameters will be:
1. Hospital Anxiety and Depression scale (HADS);
2. Care Dependency Scale (CDS);
3. Daily symptoms checklist;
4. Current smoking status and smoking history;
5. Fat-free mass (using BIA), body weight and height;
6. Physical activity (using validated accelerometer);
7. Informal and professional (medical) care <6 months;
8. Perceived social support using the Medical Outcome Study Social Support Survey (MOSSSS);
9. Post-bronchodilator spirometry;
10. Blood pressure, heart rate and oxygen saturation at rest;
11. Timed-up-and-go test;
12. Utrecht Coping List;
13. Caregiver burden and positive aspects of caregiving using the FACQ-PC;
14. A 35-item COPD knowledge questionnaire (self-developed, currently tested);
15. Dutch relationship questionnaire 2003 (Uitgever: Pearson Assessment and Information B.V.).
Other study parameters will be:
16. Demographics, including marital status;
17. Data on relationship of the loved one to the patient;
18. Medical history;
19. Current medication;
20. Charlson co-morbidity index.
- TimepointsBaseline and after 12 months. Only for patients who are admitted to the hospital because of an exacerbation, 2 additional visits are planned. The first visit, only for the loved one, within 7 days after hospital admission of the patient. The other visit, for both the patient and loved one, within 2 weeks after hospital discharge.
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESDr. Martijn A. Spruit
- CONTACT for SCIENTIFIC QUERIESDr. Martijn A. Spruit
- Sponsor/Initiator CIRO+ (Centre of expertise for chronic organ failure)
- Funding
(Source(s) of Monetary or Material Support)
Lung Foundation Netherlands, Boehringer Ingelheim Nederland
- PublicationsN/A
- Brief summaryBackground of the study:
Resident loved ones (mostly spouses or resident family members) are uniquely positioned to witness the abilities/limitations that patients with Chronic Obstructive Pulmonary Disease (COPD) experience during day-to-day life. Moreover, resident loved ones can play an important role in COPD patients’ management and well-being. To date, limited data are available specifically focussing on the resident loved ones' perception of the COPD patient’s health status, the resident loved ones' lifestyle and their possible interaction. Furthermore, loved ones' burden and health in relation to exacerbation-related hospital admission of the person with COPD are not investigated until now.

Primary objectives:
1.1 To investigate the differences between patients’ and resident loved ones' perceptions of patients’ health status and problematic ADLs. 1.2 To study prospectively the effects of an acute COPD exacerbation on resident loved ones' perceptions of patients’ health status and problematic ADLs.

Study design:
The Home Sweet Home study is an observational, longitudinal study.

Study population:
The study population consist of 192 persons with COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II, III and IV) and one resident loved one for each person with COPD.

Primary study parameters/outcome of the study:
The resident loved one, their perception of the person with COPD, and the person with COPD will be compared by using the : • Problematic ADLs using the Canadian Occupational Performance Measure (COPM) • COPD Assessment Test (CAT) • mMRC dyspnea scale • Short-Form 12 • Instrumental Activities of Daily Living Scale (IADLS) • EQ-5D • Fatigue using the Subjective Fatigue subscale of the Checklist Individual Strength • Self-efficacy for home walking.
- Main changes (audit trail)
- RECORD8-apr-2013 - 22-mei-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl